EMA Authorised: Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine) — GSK Vaccines S.r.l.

View source ↗

Summary

EMA authorised Menveo, a meningococcal group A, C, W-135 and Y conjugate vaccine, for immunization against meningococcal disease. The decision date was 11 Septe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Status: Authorised. Therapeutic area: Immunization;Meningitis, Meningococcal. MAH: GSK Vaccines S.r.l.. Decision date: 11/09/2025